Identification of structural determinants on tau protein essential for its pathological function: novel therapeutic target for tau immunotherapy in Alzheimer’s disease

Kontsekova, Eva, Zilka, Norbert, Kovacech, Branislav, Skrabana, Rostislav, Novak, Michal·2014·Alzheimer's Research & Therapy
DOI 10.1186/alzrt277

Cited by (113)

Items 101–113 of 113

  1. Immunotherapies for Alzheimer’s Disease
    Hui Juan Guo · 2022 · Advances in Social Science, Education and Humanities Research/Advances in social science, education and humanities research
  2. Noninfectious Disease Vaccines
    Daniel E. Speiser, Aadil El-Turabi, Martin F. Bachmann · 2023 · Elsevier eBooks
  3. Cyclization Scaffolding for Improved Vaccine Immunogen Stability: Application to Tau Protein in Alzheimer’s Disease
    Shawn C. C. Hsueh, Mark Nijland, Adekunle Aina, Steven Samuel Plotkin · 2024 · Journal of Chemical Information and Modeling
  4. Biomarkers for Proteostasis Disruption: An Overview
    Deena Prakash, Divya Bisht · 2025 · Springer eBooks
  5. Nonamyloid-beta active immunization for the treatment of Alzheimer’s disease
    Olivia Triplett, Nicole Varda, Boris Decourt, Marwan Noel Sabbagh · 2025 · Expert Opinion on Investigational Drugs
  6. Implications de la protéine DYRK1A dans la pathologie Alzheimer et développement de stratégies thérapeutiques
    Benoît Souchet · 2018 · theses.fr (ABES)
  7. Prévention du phénomène de nucléation et de la propagation des tauopathies par immunothérapie passive utilisant un anticorps ciblant une région centrale de la protéine tau
    Marie Albert · 2018 · theses.fr (ABES)
  8. Gradual N-terminal truncation of tau dGAE (297–391) reveals the importance of 321–325 sequence for early steps of fibril formation
    Stefana Njemoga, Petra Majerová, Juraj Piešťanský, Zuzana Gažová, Pavel Kadeřávek, Exequiel Barrera, Zuzana Bednáriková, Ondrej Cehlár · 2026 · International Journal of Biological Macromolecules
  9. Multitarget pharmacological effects of Lawsone in mitigating Alzheimer's disease
    Muhammad Adnan Bashir, Ihsan Ullah, Gulshan Aara, Arif‐ullah Khan, Syed Uzair Ali Shah · 2026 · European Journal of Pharmacology
  10. Formation and toxicity of protein misfolded oligomers: Mechanistic insights and therapeutic opportunities in protein aggregation diseases
    Lorenzo Neri, Carol A. Anderson, Lucas B. Fallot, Benedetta Mannini, Ryan Limbocker · 2026 · Elsevier eBooks
  11. A Virus-Like-Particle-Based Conjugate Vaccine Targeting the Microtubule Binding Region of Tau Protein
    Hunter McFall-Boegeman, Cameron Talbot, Mauro Montalbano, Nicha Puangmalai, Kuang-Wei Wang, Meena Kannan, Jiaming Shi, Katrina Linning‐Duffy, Setare Nick, Lily Yan et al. · 2026 · ACS Omega
  12. Targeting protein aggregate co-pathologies in neurodegeneration: a viable therapeutic strategy?
    Silas A. Buck, Sidharth S. Madhavan, Laurie H. Sanders · 2026 · Molecular Neurodegeneration Advances
  13. BindingDB Entry 50002303: Tau protein aggregation in Alzheimer's disease: An attractive target for the development of novel therapeutic agents.
    BindingDB · 2020 · UC San Diego